Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus −1: an in vitro study on virally infected Vero and MRC-5 cell lines

Abstract

BackgroundNew sources for discovering novel antiviral agents are desperately needed. The current antiviral products are both expensive and not very effective.MethodsThe antiviral activity of methanol extract of mung bean sprouts (MBS), compared to Ribavarin and Acyclovir, on respiratory syncytial virus (RSV) and Herpes Simplex virus −1 (HSV-1) was investigated using cytotoxicity, virus yield reduction, virucidal activity, and prophylactic activity assays on Vero and MRC-5 cell lines. Moreover, the level of antiviral cytokines, IFNβ, TNFα, IL-1, and IL-6 was assessed in MBS-treated, virally infected, virally infected MBS-treated, and control groups of MRC-5 cells using ELISA.ResultsMBS extract showed reduction factors (RF) 2.2 × 10 and 0.5 × 102 for RSV and HSV-1, respectively. The 2 h incubation virucidal and prophylactic selectivity indices (SI) of MBS on RSV were 14.18 and 12.82 versus Ribavarin SI of 23.39 and 21.95, respectively, and on HSV-1, SI were 18.23 and 10.9 versus Acyclovir, 22.56 and 15.04, respectively. All SI values were >10 indicating that MBS has a good direct antiviral and prophylactic activities on both RSV and HSV-1. Moreover, interestingly, MBS extract induced vigorously IFNβ, TNFα, IL-1, and IL-6 cytokines in MRC-5 infected-treated group far more than other groups (P < 0.05) and induced TNFα and IL-6 in treated group more than infected group (P < 0.05).ConclusionsMBS extract has potent antiviral and to a lesser extent, prophylactic activities against both RSV and HSV-1, and in case of HSV-1, these activities were comparable to Acyclovir. Part of the underlying mechanism(s) of these activities is attributed to MBS potential to remarkably induce antiviral cytokines in human cells. Hence, we infer that MBS methanol extract could be used as such or as purified active component in protecting and treating RSV and HSV-1 infections. More studies are needed to pinpoint the exact active components responsible for the MBS antiviral activities.

Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol

“…HSV-1 virus titer was measured by 50% tissue culture infective dose (TCID50) method as described elsewhere (Hafidh et al 2015). Briefly, Vero cells (1.5 9 10 4 cells/ well) were cultured in 96-well plates.…”

Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19

“…Moreover, they found that haloperidol decreased viral replication in SARS-CoV-2-infected Vero E6 cells with, based on their reported pIC50 and pCC50 values, a calculated Selectivity Index (SI) of 53.7 12 . An SI greater than 10 is the generally accepted minimum cut-off for an antiviral worth pursuing 36,37 . In another more recent study, Gordon et al found in their analysis of a national electronic medical record database that fewer hospitalized COVID-19 patients who were newly prescribed haloperidol and other sigma-binding typical antipsychotic medications progressed to requiring mechanical ventilation compared to those who were newly prescribed atypical antipsychotic medications that do not bind to sigma receptors 14 .…”

A comprehensive anticancer molecular study for genistein the promising anticancer drug

“…10 A potent antiviral and anticancer effect from beans or their sprout extracts have discovered by many studies. 11,12 Furthermore, genistein, an isoflavone finds in many plants especially soybeans and fava beans proved to be highly effective anticancer compound. 2,3,6 The results of this study have clarified the real anticancer mechanism of this highly promising anticancer drug, Genistein anticancer molecular mechanism Original Rand R. Hafidh genistein.…”